Takeda and CiRA announce comprehensive joint research agreement.

Takeda Pharmaceuticals and Kyoto University’s CiRA announced that they will work together to develop clinical applications of induced pluripotent stem cells in areas such as heart failure, diabetes mellitus, neurological disorders and cancer immunotherapy. The...

Japanese team establishs „organ buds“ for organ regeneration

The groups of Hideki TANIGUCH at Saitama University and Takanori TAKEBE at Yokohama City University have developed a technology which allows the formation of organ buds from mesenchymal cells. As an example, 3D kidney tissue which produced urine and pancreatic tissue...

J-TEC offers autologous cultured cartilage nation-wide

The product ist he second regenerative medicine product registered in Japan. It is listed by health insurances and used fort he treatment of traumatic cartilage deficiency or osteochondritis dissecans in knee joints. Chondrocytes are harvested from the joint oft he...